Please try another search
As of September 29, 2023, Graf Acquisition Corp. IV was acquired by NKGen Biotech, Inc., in a reverse merger transaction. Graf Acquisition Corp. IV does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. Graf Acquisition Corp. IV was incorporated in 2021 and is based in The Woodlands, Texas.
Name | Age | Since | Title |
---|---|---|---|
Michael L. Klowden | 77 | 2023 | Independent Director |
Anthony T. Reder | - | 2023 | Member of Scientific Advisory Board |
Craig Blackstone | - | 2023 | Member of Scientific Advisory Board |
Kathleen D. Scott | - | 2023 | Independent Director |
Evren Alici | - | - | Member of Scientific Advisory Board |
Ming Guo | - | 2023 | Member of Scientific Advisory Board |
Yong Ben | 49 | - | Scientific & Clinical Advisor |
Paul Y. Song | 58 | 2023 | CEO & Chairman |
Sangwoo Park | 54 | 2023 | Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review